BridgeMD
Tests treatment safety and results for Primary Immune Thrombocytopenia
Official title Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
ClinicalTrials.gov ID: NCT05070845
What this study is testing
What is PF-06835375?
PF-06835375 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for primary immune thrombocytopenia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with primary immune thrombocytopenia (ITP). This study will focus on participants with persistent (\>3 months and ≤12 months), or chronic (\>12 months) ITP
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Diagnosis of Primary ITP. Ongoing ITP (platelet counts \ 12 months
You likely can't join if
- Bleeding event according to the WHO grading scale ≥2 occurring ≤4 weeks prior to screen OR a current bleeding event that, in the opinion of the...
- Splenectomy within 3 months of randomization or planned during the study duration.
The study team makes the final eligibility decision.
Where it's taking place
- Greenville, North Carolina, United States
- Liverpool, New South Wales, Australia
- Mount Kuring-Gai, New South Wales, Australia
- Waratah, New South Wales, Australia
- Bedford Park, South Australia, Australia
- Kurralta Park, South Australia, Australia
- Melbourne, Victoria, Australia
- Perth, Western Australia, Australia
- Toronto, Ontario, Canada
- Montreal, Quebec, Canada
- Hradec Králové, Czechia
- Ostrava - Poruba, Czechia
- Prague, Czechia
- Pécs, Baranya, Hungary
- Kaposvár, Somogy County, Hungary
- Budapest, Hungary
- Győr, Hungary
- Szekszárd, Hungary
- Tatabánya, Hungary
- Skórzewo, Greater Poland Voivodeship, Poland
+ 9 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Greenville, North Carolina, United States; Liverpool, New South Wales, Australia; Mount Kuring-Gai, New South Wales, Australia; Waratah, New South Wales, Australia; Bedford Park, South Australia, Australia; Kurralta Park, South Australia, Australia and 23 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.